Recursion Pharmaceuticals, Inc. RXRX Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s compensation and benefits?
- Recursion Pharmaceuticals, Inc. (RXRX) reported compensation and benefits of $14.57M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s compensation and benefits changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s compensation and benefits decreased by 35.1% year-over-year, from $22.46M to $14.57M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s compensation and benefits?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s compensation and benefits has grown at a 59.4% compound annual growth rate (CAGR), from $3.09M to $31.77M.